Lee Ainslie - Maverick Capital
Holding/activity history for Takeda Pharmaceutical Co. Ltd. (TAK)
← All TAK superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2020 Q1 | 0 | 0.00 | Sell 100.00% | 0.21 | $12.43–20.42 · VW $17.01i | SEC | |
| 2019 Q4 | 716,145 | 0.21 | Reduce 6.31% | 0.01 | $16.82–20.93 · VW $19.00i | $14,130,000 | SEC |
| 2019 Q3 | 764,401 | 0.19 | Reduce 54.58% | 0.23 | $16.10–18.16 · VW $17.26i | $13,148,000 | SEC |
| 2019 Q2 | 1,682,888 | 0.43 | Reduce 3.37% | 0.02 | $16.46–20.76 · VW $18.09i | $29,787,000 | SEC |
| 2019 Q1 | 1,741,666 | 0.48 | Add 352.38% | 0.37 | $16.20–21.61 · VW $19.48i | $35,478,000 | SEC |
| 2018 Q4 | 385,000 | 0.10 | Buy | 0.10 | $15.50–21.15 · VW $18.06i | $6,476,000 | SEC |
Price snapshot:
Current price$16.49
52-week low$12.99
52-week high$18.90